Distinct VEGF Functions During Bone Development and Homeostasis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 62, Issue 5, 2014, Pages 363-368

  Liu, Yanqiu ^a,b   Olsen, Bjorn R ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Adipocyte; Differentiation; Mesenchymal stem cells; Ossification; Osteoblast; VEGF

Indexed keywords

NEUROPILIN; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

BONE DEVELOPMENT; CARTILAGE MATRIX; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; MECHANOTRANSDUCTION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOID; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULARIZATION; ANGIOGENESIS; ANIMAL; CARTILAGE CELL; MESENCHYMAL STROMA CELL; MOUSE; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CHONDROCYTES; HOMEOSTASIS; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84919843908     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-014-0285-y     Document Type: Review

References (45)

1. Alonso V, de Gortazar AR, Ardura JA et al (2008) Parathyroid hormone-related protein (107–139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2. J Cell Physiol 217:717–727
2. Beresford JN, Bennett JH, Devlin C et al (1992) Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102(Pt 2):341–351
3. Clarkin CE, Garonna E, Pitsillides AA et al (2008) Heterotypic contact reveals a COX-2-mediated suppression of osteoblast differentiation by endothelial cells: a negative modulatory role for prostanoids in VEGF-mediated cell: cell communication? Exp Cell Res 314:3152–3161
4. Conn G, Bayne ML, Soderman DD et al (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628–2632
5. Costa N, Paramanathan S, Mac Donald D et al (2009) Factors regulating circulating vascular endothelial growth factor (VEGF): association with bone mineral density (BMD) in post-menopausal osteoporosis. Cytokine 46:376–381
6. Deckers MM, Karperien M, van der Bent C et al (2000) Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141:1667–1674
7. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676
8. Fong GH, Zhang L, Bryce DM et al (1999) Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 126:3015–3025
9. Gao J, Yang T, Han J et al (2011) MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow. J Cell Biochem 112:1844–1856
10. Gerber HP, Vu TH, Ryan AM et al (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623–628
11. Gerber HP, Malik AK, Solar GP et al (2002) VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417:954–958
12. Guillotin B, Bareille R, Bourget C et al (2008) Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone 42:1080–1091
13. Harper J, Gerstenfeld LC, Klagsbrun M (2001) Neuropilin-1 expression in osteogenic cells: down-regulation during differentiation of osteoblasts into osteocytes. J Cell Biochem 81:82–92
14. Karsenty G (2003) The complexities of skeletal biology. Nature 423:316–318
15. Kodama H, Yamasaki A, Nose M et al (1991) Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med 173:269–272
16. Kronenberg HM (2003) Developmental regulation of the growth plate. Nature 423:332–336
17. Lee S, Chen TT, Barber CL et al (2007) Autocrine VEGF signaling is required for vascular homeostasis. Cell 130:691–703
18. Liu Y, Berendsen AD, Jia S et al (2012) Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest 122:3101–3113
19. Maes C, Stockmans I, Moermans K et al (2004) Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 113:188–199
20. Matsubara H, Hogan DE, Morgan EF et al (2012) Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis. Bone 51:168–180
21. Mayr-Wohlfart U, Waltenberger J, Hausser H et al (2002) Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30:472–477
22. Midy V, Plouet J (1994) Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 199:380–386
23. Nakagawa M, Kaneda T, Arakawa T et al (2000) Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473:161–164
24. Nicosia RF, Nicosia SV, Smith M (1994) Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145:1023–1029
25. Niida S, Kaku M, Amano H et al (1999) Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190:293–298
26. Nuttall ME, Patton AJ, Olivera DL et al (1998) Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res 13:371–382
27. Otomo H, Sakai A, Uchida S et al (2007) Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential. Bone 40:1494–1501
28. Park JE, Chen HH, Winer J et al (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646–25654
29. Pepper MS, Ferrara N, Orci L et al (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824–831
30. Pepper MS, Wasi S, Ferrara N et al (1994) In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Exp Cell Res 210:298–305
31. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147
32. Prockop DJ (2012) New targets for osteoporosis. N Engl J Med 367:2353–2354
33. Schipani E, Ryan HE, Didrickson S et al (2001) Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15:2865–2876
34. Shalaby F, Rossant J, Yamaguchi TP et al (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62–66
35. Soker S, Takashima S, Miao HQ et al (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92:735–745
36. Song L, Tuan RS (2004) Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. FASEB J 18:980–982
37. Tanaka S, Takahashi N, Udagawa N et al (1993) Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest 91:257–263
38. Thi MM, Suadicani SO, Spray DC (2010) Fluid flow-induced soluble vascular endothelial growth factor isoforms regulate actin adaptation in osteoblasts. J Biol Chem 285:30931–30941
39. Verma S, Rajaratnam JH, Denton J et al (2002) Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 55:693–698
40. Wang Y, Wan C, Deng L et al (2007) The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616–1626
41. Yang Q, McHugh KP, Patntirapong S et al (2008) VEGF enhancement of osteoclast survival and bone resorption involves VEGF receptor-2 signaling and beta3-integrin. Matrix Biol 27:589–599
42. Zelzer E, Olsen BR (2003) The genetic basis for skeletal diseases. Nature 423:343–348
43. Zelzer E, Olsen BR (2005) Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 65:169–187
44. Zelzer E, McLean W, Ng YS et al (2002) Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129:1893–1904
45. Zelzer E, Mamluk R, Ferrara N et al (2004) VEGFA is necessary for chondrocyte survival during bone development. Development 131:2161–2171